Laboratorios Farmaceuticos Rovi, S.A. (BIT:1ROVI)
Italy · Delayed Price · Currency is EUR 72.65
-5.70 (-7.28%)
At close: Feb 11, 2026
BIT:1ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 210.47M EUR in the quarter ending September 30, 2025, a decrease of -10.54%. This brings the company's revenue in the last twelve months to 724.20M, down -9.39% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75M, down -7.93%.
Revenue (ttm)
724.20M
Revenue Growth
-9.39%
P/S Ratio
5.45
Revenue / Employee
329.63K
Employees
2,188
Market Cap
3.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Webuild | 12.15B |
| Iren SpA | 6.69B |
| Nexi S.p.A. | 6.34B |
| Danieli & C. Officine Meccaniche | 4.20B |
| Brembo | 3.75B |
| Reply | 2.48B |
| Amplifon | 2.41B |
| SOL S.p.A. | 1.73B |